Cargando…
Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy
OBJECTIVE: Diabetic retinopathy (DR) is the retinal consequence of chronic progressive diabetic microvascular leakage and occlusion. Non-proliferating diabetic retinopathy (NPDR) is the early stage of DR. It eventually occurs to some degree in all patients with diabetes mellitus. In recent years, ma...
Autores principales: | Wang, Yu, Hao, Lei, Huo, Zhipeng, Liu, Yuanxue, Sun, Yujing, Song, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476495/ https://www.ncbi.nlm.nih.gov/pubmed/36120120 http://dx.doi.org/10.1016/j.chmed.2021.08.002 |
Ejemplares similares
-
Recommendations on the Clinical Use of Compound Danshen Dripping Pills
Publicado: (2017) -
Proangiogenesis effects of compound danshen dripping pills in zebrafish
por: Hu, Yang-Xi, et al.
Publicado: (2022) -
Compound Danshen Dripping Pill for Treating Nonproliferative Diabetic Retinopathy: A Meta-Analysis of 13 Randomized Controlled Trials
por: Huang, Wenjing, et al.
Publicado: (2017) -
Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
por: Liu, Le, et al.
Publicado: (2022) -
Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study
por: Luo, Dan, et al.
Publicado: (2015)